Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering – Feb 01, 2021
The Pharma Data
JANUARY 31, 2021
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Yield10 Bioscience, Inc. Safe Harbor for Forward-Looking Statements.
Let's personalize your content